Release Date: 25/02/20 19:54 Summary: H1 FY20 Results Release Cover Note Price Sensitive: No Download Document 255.99KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%